Examining HIV Stigma, Depression, Stress, and Recent Stimulant Use in a Sample of Sexual Minority Men Living with HIV: An Application of the Stigma and Substance Use Process Model

AIDS Behav. 2022 Jan;26(Suppl 1):138-148. doi: 10.1007/s10461-021-03517-0. Epub 2021 Nov 6.

Abstract

Sexual minority men (SMM) with HIV are disproportionately impacted by stigma and mental health disorders. Guided by the Stigma and Substance Use Process Model, we evaluated how HIV stigma impacts mental health outcomes among SMM with HIV. Data were drawn from Thrive With Me, an RCT of an mHealth intervention targeting ART adherence among SMM with HIV. Path analyses tested the relationships between HIV stigma, depression, stress, and recent stimulant use. Overall, 49.1% (194/401) had depression symptoms, 68.8% (276/401) had moderate-to-high stress, and 28.1% (111/401) had detectable stimulant use in urine samples at baseline. In path analyses, baseline internalized HIV stigma was associated with depression and stress 5-months post-baseline and enacted stigma was associated with recent stimulant use 11-months post-baseline. We identified internalized and enacted HIV stigma, but not anticipated stigma, as potentially important intervention targets for stimulant use, depression, and stress among SMM with HIV.

Keywords: Depression; Enacted HIV stigma; Internalized HIV stigma; Stimulant use; Stress.

MeSH terms

  • Depression / epidemiology
  • HIV Infections* / drug therapy
  • Humans
  • Male
  • Sexual and Gender Minorities*
  • Social Stigma
  • Substance-Related Disorders* / epidemiology